コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ulators of Wnt activity, sodium butyrate and lithium chloride.
2 s the colonic lumen is readily accessible to lithium chloride.
3 eta was abolished by the GSK3 beta inhibitor lithium chloride.
4 sucrose solution by pairing consumption with lithium chloride.
5 els by specific inhibition of GSK3beta using lithium chloride.
6 was paired with an injection of the emetic, lithium chloride.
7 ired with concurrent or delayed infusions of lithium chloride.
8 e suppressive effects of the aversive agent, lithium chloride.
9 catalysis is required for chlorination with lithium chloride.
10 e absence of PI3K signaling was induced with lithium chloride.
11 avor X alone was paired with the delivery of lithium chloride.
12 glycogen synthase kinase-3 (GSK-3) inhibitor lithium chloride.
14 ed when given together with a single dose of lithium chloride (a nonselective GSK-3 inhibitor) or a p
15 atment in PbA-infected mice, the addition of lithium chloride, a compound which inhibits GSK3beta act
17 pidly, were protected from apoptosis by both lithium chloride, a GSK3 selective inhibitor, and inhibi
18 or the first time, the beneficial effects of lithium chloride, a reversible inhibitor of the glycogen
20 hat flavor (satiation) or by pairing it with lithium chloride (acquired taste aversion), while the ot
22 Furthermore, in utero treatment with either lithium chloride, an agonist of canonical Wnt signaling,
26 es amylin and cholecystokinin, as well as by lithium chloride and lipopolysaccharide, compounds that
28 he physical chemistry of molten solutions of lithium chloride and metallic lithium, with and without
31 scued from NVP-AEW541 by GSK3beta inhibitor, lithium chloride and were sensitized by GSK3beta activat
32 ss to sucrose and subsequently injected with lithium chloride, and a test phase in which animals were
35 ) inhibitors, especially the mood stabilizer lithium chloride, are also used as neuroprotective or an
37 echanical rotation, or late, by injection of lithium chloride (at 32 cells) or of the transcription f
38 the same effects in wild-type mice, whereas lithium chloride, at doses that produce conditioned tast
39 on, when GSK-3beta activity was inhibited by lithium chloride, both c-fos promoter activity and prote
40 orced expression of Wnt-1 and treatment with lithium chloride, both of which inhibit neural different
41 abrogated by nonspecific GSK3beta inhibitor lithium chloride but not by selective inhibitor SB216763
44 ion is mediated by electronically stabilized lithium chloride carbenoids and affords a variety of dif
45 A, which encodes the cardiac sodium channel, lithium chloride caused concentration-dependent block of
46 ively regulated by AKT, using AR-A014418 and lithium chloride completely abolished LY294002-induced N
52 dress this issue by employing a concentrated lithium chloride electrolyte, which stabilizes reactive
53 Conditioned taste aversions (CTA) based on lithium chloride (Experiment 1), amphetamine (Experiment
56 cyclic carbene (NHC) require the addition of lithium chloride for high levels of enantioselectivity.
58 of three steps: (1) loading the sorbent with lithium chloride from brine; (2) intermediate washing to
60 eding behaviour of peptide YY3-36 (PYY3-36), lithium chloride, glucagon-like peptide 1 (GLP-1), and l
62 o-T286 cyclin D1 expression was inhibited by lithium chloride, implicating GSK3 in these effects.
67 o blocked acquisition of ethanol-induced and lithium chloride-induced conditioned place aversion but
68 both WT and DAT-Ala53 mice exhibited similar lithium chloride-induced CPA and morphine-induced CPP.
69 AC) that had previously been associated with lithium chloride-induced malaise, c-Fos protein expressi
71 r flavors paired with toxic drug treatments (lithium chloride infusion or methylscopolamine injection
76 mation and suspension of lithium clusters in lithium chloride is the cause of various phenomena exhib
77 lyte reduction to sulfur, sulfur dioxide and lithium chloride, is well known for its high energy dens
78 iodides with indium metal in the presence of lithium chloride leads to the formation of an organoindi
83 s of C57BL/6J fetal mice pretreated with E2, lithium chloride (LiCl) and combined E2/LiCl for 12, 24
84 followed by an intraperitoneal injection of lithium chloride (LiCl) and served to pair the memory of
85 oral effects of short-term administration of lithium chloride (LiCl) and valproic acid (VPA) in rats.
87 raoral sucrose with malaise via injection of lithium chloride (LiCl) caused the development of a cond
88 ontaining WNT3A or the WNT pathway activator lithium chloride (LiCl) display accelerated formation of
90 0.3% oral saccharin (SAC) and 81 mg/kg i.p. lithium chloride (LiCl) followed by extinction training
91 d the dorsalizing effects of the Wnt agonist lithium chloride (LiCl) in embryos, and this effect requ
93 n their home cages immediately followed by a lithium chloride (LiCl) injection on 3 consecutive days.
94 eck a bead presented 15 or more min before a lithium chloride (LiCl) injection, but would peck a bead
95 that N,N-dimethylacetamide (DMA) containing lithium chloride (LiCl) is a privileged solvent that ena
96 -catenin knockdown embryos, dorsalization by Lithium chloride (LiCl) is mediated by Nodals, Dkk1 exer
97 hen it is paired with an aversive agent like lithium chloride (LiCl) or a preferred substance such as
98 P-1) and intraperitoneal (i.p.) injection of lithium chloride (LiCl) produce similar patterns of c-Fo
99 ulocyte-colony stimulating factor (G-CSF) or lithium chloride (LiCl) produced synergistic terminal di
101 Peripheral administration of large doses of lithium chloride (LiCl) to rats causes a spectrum of eff
102 conditioned taste aversion (CTA) induced by lithium chloride (LiCl) toxicosis (Experiments 1 and 4).
105 in and Col1a1 expression can be increased by lithium chloride (LiCl) treatment in the in vitro tooth
106 ogen synthase kinase 3 (GSK3) inhibition via lithium chloride (LiCl) treatment on SERCA uncoupling in
107 of appetite-suppressing substances including lithium chloride (LiCl), a compound often used to induce
109 Additionally, exogenous compounds, such as lithium chloride (LiCl), a salt that creates gastric dis
111 ointestinal (GI) infusion of 1 nutrient with lithium chloride (LiCl), whereas they could not discrimi
113 ation on subsequent acquisition of EtOH- and lithium chloride (LiCl)-induced conditioned taste aversi
114 orphine treatment on cocaine-, sucrose-, and lithium chloride (LiCl)-induced suppression of saccharin
115 IN2 siRNA reduces inhibitory GSK3 levels and lithium chloride (LiCl)-upregulated beta-catenin or CCAA
120 ered intraperitoneal injections of saline or lithium chloride (LiCl; .15 M) following exposure to a n
121 ral saccharin (SAC; the CS) and 81mg/kg i.p. lithium chloride (LiCl; the US)] followed by extinction
123 and chemical resolution of the interface of lithium chloride - lithium bis(trifluoromethanesulfonyl)
124 acetaldehyde (lithium vinyloxide, LiOV) and lithium chloride, lithium bromide, and lithium amides.
127 expression of constitutively active AKT and lithium chloride-mediated inhibition of GSK3beta reduce
128 dard saccharin CS paired with the following: lithium chloride, morphine, amphetamine, or sucrose.
131 y, treatment with the autophagic stimulators lithium chloride or rapamycin reverses the bioenergetic
133 mutant beta-catenin, treatment of cells with lithium chloride, or with wnt3a-conditioned medium, thre
134 le research has been done on its role in the lithium chloride-pilocarpine induced epileptic model.
135 e Sprague Dawley (SD) rats were treated with lithium chloride-pilocarpine injections and divided into
136 plar MS system used for characterization was lithium chloride/potassium chloride eutectic (LKE), whic
138 cking it using a dominant-negative mutant or lithium chloride prevented mTORC1-induced accelerated ax
141 administration of an aversive agent such as lithium chloride (referred to as a conditioned taste ave
142 slation by cycloheximide, or of autophagy by lithium chloride, rescued viability, preserved cellular
146 ctivity using either a specific inhibitor or lithium chloride significantly reduced tau phosphorylati
147 Transmetalation with zinc chloride then (lithium chloride solubilized) copper cyanide followed by
149 ater-water H-bonding present in concentrated lithium chloride solutions (up to four waters per ion pa
150 oncentrations, and apply our method to study lithium chloride solutions at concentrations >0.5 M.
151 he glycogen synthase kinase-3 beta inhibitor lithium chloride suppressed the glycogen synthase kinase
153 brain areas consequent to administration of lithium chloride, the typical illness-inducing agent use
156 ngly with degree of axonal degeneration, and lithium-chloride-treated mice showed less degeneration i
158 increased basal beta-catenin levels, such as lithium chloride treatment or repression of caveolin-1 e
159 activation of Wnt/beta-catenin signaling by lithium chloride treatment reduced the number and activi
162 egenerating dorsal and ventral half-embryos, lithium chloride treatment, and the overexpression of Wn
165 Treatment of cells with a Wnt activator, lithium chloride, up-regulated DPAGT1 transcript levels
166 ton Sea geothermal brine and purification of lithium chloride using intercalation materials, and conv
169 tablished in golden hamsters by injection of lithium chloride, were quantified as percent suppression
170 oderm-specific genes can be induced by 25 mM lithium chloride, which also induced endoderm formation.
172 The IC50 for glycogen synthase peptide and lithium chloride, which has been reported to be uncompet
174 lial cells; activation of Wnt signaling with lithium chloride, which stabilizes beta-catenin levels,